Physician profile
Amanda Johnson
NPI 1245457670
$1,039.70
in general payments reported to CMS, 2019-2025
11 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $312 · 2023: $215 · 2024: $109 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $336.00 | 2021-2022 | |
| Abbvie INC. | $283.09 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $170.24 | 2022-2023 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $54.84 | 2024-2025 | Fruzaqla, Ninlaro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.74 | 2023 | Lifevest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.74 | 2023 | Xifaxan |
| Tersera Therapeutics LLC | $38.51 | 2023 | Zoladex |
| E.R. Squibb & Sons, L.L.C. | $23.19 | 2023 | Eliquis |
| Bioxcel Therapeutics, INC. | $18.49 | 2023 | Igalmi |
| Merck Sharp & Dohme LLC | $15.55 | 2023 | Verquvo |
| Myriad Women'S Health, INC. | $13.31 | 2023 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.